| [1] | 宋建虹,杜小莉. 新型口服抗血小板活化和聚集药物——普拉格雷[J].中国药学杂志, 2010,45(17);1357. |
| [2] | Jakubowski JA,Winters KJ,Naganuma H,et al. Prasugrel:a novel thienopyridine antiplatelet agent.A review of preclinical and clinical studies and the mechanistic basis for its distinct antiplatelet profile[J].Cardiovascular Drug Rev, 2007, 25(4):357. |
| [3] | Alain B,Daniel F,Jian-Pierre M,et al. Derivatives of alpha(2-oxo-2,4,5,6,7,7a-hexahy drothieno[3,2-c]-5-pyridyl) phenyl acetic acid,and their use as platelet and thrombotic aggregation inhibitiors[P].US.4740510,1988-04-26. |
| [4] | Hiroyuki K,Fumitoshi A,Atsuhiro S,et al. Tetra-hydrothienopyridine derivatives, furo and pyrrolo analogs thereof and their preparation and uses for inhibiting blood platelet aggregation[P].EP 0542411,1993-05-19. |
| [5] | 吴雪松,岑均达,郭 珩. 制备普拉格雷的中间体及其制备方法[P].CN101245072A, 2008-08-20. |
| [6] | 程兴栋,童 玲, 杨玉雷,等. 普拉格雷的合成工艺研究[J].中国新药杂志, 2010,19(15);1314. |